Erythropoiesis-stimulating agents : development, detection and dangers
Gespeichert in:
| Deutscher übersetzter Titel: | Erythropoetin-stimulierende Wirkstoffe : Entwicklung, Nachweis und Gefahren |
|---|---|
| Autor: | Franz, Stefan E. |
| Erschienen in: | Drug testing and analysis |
| Veröffentlicht: | 1 (2009), 6, S. 245-249, Lit. |
| Format: | Literatur (SPOLIT) |
| Publikationstyp: | Zeitschriftenartikel |
| Medienart: | Gedruckte Ressource Elektronische Ressource (online) |
| Sprache: | Englisch |
| ISSN: | 1942-7603, 1942-7611 |
| DOI: | 10.1002/dta.51 |
| Schlagworte: | |
| Online Zugang: | |
| Erfassungsnummer: | PU201007005534 |
| Quelle: | BISp |
TY - JOUR AU - Franz, Stefan E. A2 - Franz, Stefan E. DB - BISp DP - BISp KW - Blutdoping KW - Doping KW - Dopinganalyse KW - Dopingnachweis KW - Erythropoese KW - Erythropoetin KW - Gesundheitsgefährdung KW - Hämatologie KW - Sportaktivität LA - eng TI - Erythropoiesis-stimulating agents : development, detection and dangers TT - Erythropoetin-stimulierende Wirkstoffe : Entwicklung, Nachweis und Gefahren PY - 2009 N2 - Epoetin alfa, the first member of the family of erythropoiesis stimulating agents (ESAs), was introduced to the market in 1989. Since then development has progressed to epoetins of the third generation. Currently drugs that use alternative approaches to stimulate erythropoiesis are under development. Uptake of all available ESAs into doping has occurred rapidly after their introduction. A multitude of dangers to health are associated with the illicit use of these substances. Different approaches to detect ESAs in doping control have been developed to comply with the very diverse nature of the compounds used. Verf.-Referat L2 - https://dx.doi.org/10.1002/dta.51 DO - 10.1002/dta.51 SP - S. 245-249 SN - 1942-7603 JO - Drug testing and analysis IS - 6 VL - 1 M3 - Gedruckte Ressource M3 - Elektronische Ressource (online) ID - PU201007005534 ER -